| P50 | author | Sooseong You | Q56528898 |
| P2093 | author name string | Hoyoung Lee | |
| | Eun Hyoung Shim | |
| P2860 | cites work | Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. | Q30356901 |
| | Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children | Q33883224 |
| | A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies | Q34304888 |
| | Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | Q34783486 |
| | Haemagglutination-inhibiting antibody to influenza virus | Q35747515 |
| | Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination | Q36306922 |
| | Impact of host genetic polymorphisms on vaccine induced antibody response | Q37130716 |
| | Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time | Q37591325 |
| | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis | Q38639994 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Defining B cell immunodominance to viruses | Q40335009 |
| | Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. | Q40901873 |
| | Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? | Q47428977 |
| | Influenza hemagglutinin-mediated membrane fusion: influence of receptor binding on the lag phase preceding fusion | Q72528362 |
| | Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005 | Q83273637 |
| P433 | issue | 10 | |
| P304 | page(s) | 2537-2539 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Immunodominance hierarchy of influenza subtype-specific neutralizing antibody response as a hurdle to effectiveness of polyvalent vaccine | |
| P478 | volume | 14 | |